Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)

NCT00892866 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT00892866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00892866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Lead sponsor
GOG Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
April 13, 2009
Completion date
May 31, 2025
Enrollment
877 (estimated)
Sites
163

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, human papillomavirus infection, stage 0 cervical cancer ajcc v7